نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشجوی دکتری فیزیولوژی ورزشی، دانشکده تربیت بدنی و علوم ورزشی، دانشگاه تبریز، تبریز، ایران.

2 استاد گروه فیزیولوژی ورزشی، دانشکده تربیت بدنی و علوم ورزشی، دانشگاه تبریز، تبریز، ایران.

3 دانشیار گروه فیزیولوژی ورزشی، دانشکده تربیت بدنی و علوم ورزشی، دانشگاه تبریز، تبریز، ایران.

چکیده

زمینه و هدف: آسپروسین از بافت چربی ترشح می‌‌شود و نقش اساسی در تنظیم متابولیسم گلوکز و تنظیم اشتها بر عهده دارد و ممکن است یک هدف درمانی برای پیشگیری از بیماری‌‌هایی مانند چاقی، دیابت نوع دو و مقاومت به انسولین باشد. از این‌‌رو، مطالعه حاضر با هدف بررسی تأثیر تمرین تناوبی با شدت بالا (HIIT) بر مقدار سرمی آسپروسین و پروفایل لیپیدی در زنان دارای اضافه وزن و چاقی انجام شد. روش تحقیق: تعداد 30 زن دارای اضافه وزن و چاق ( با 28≤BMI) با دامنه سنی 45-30 سال، در قالب یک طرح مطالعاتی نیمه تجربی با دو مرحله پیش آزمون- پس آزمون، به صورت هدفمند انتخاب شدند و به طور تخصیص تصادفی به دو گروه 15 نفره شامل تمرین تناوبی شدید (HIIT) و کنترل تقسیم گردیدند. دوره آماده‌‌سازی به مدت دو هفته و HIIT به مدت هشت هفته، سه جلسه در هفته با 100 درصد حداکثر ضربان قلب ذخیره به اجرا درآمد. نمونه‌‌های خونی قبل از شروع تمرینات و  48 ساعت بعد از آخرین جلسه تمرینی (بعد از اتمام 10 هفته تمرین) اخذ گردید. مقدار آسپروسین و نیمرخ لیپیدی به ترتیب با روش الایزا و اسپکتروفوتومتری اندازه‌‌گیری شدند. داده‌‌ها با استفاده از آزمون t مستقل و t زوجی و در سطح معنی‌‌داری 05/0>p تجزیه و تحلیل گردیدند. یافته‌‌ها: بعد از 10 هفته مداخله، گروه HIIT کاهش معنی‌‌داری در مقدار آسپروسین (02/0=p)، تری‌‌گلیسرید (01/0=p)، کلسترول تام (01/0=p)، لیپوپروتئین کلسترول با چگالی‌‌کم (01/0=p)، لیپوپروتئین کلسترول با چگالی خیلی‌‌کم (01/0=p)، وزن (0001/0=p)، درصد چربی (0001/0=p) و شاخص توده بدنی (0001/0=p)؛ و افزایش معنی‌‌داری در حداکثر اکسیژن مصرفی (0001/0=p) داشت. با این‌‌حال، تغییر معنی‌‌داری در مقدار لیپوپروتئین کلسترول با چگالی بالا (05/0<p) مشاهده نشد. نتیجه گیری: احتمالا انجام HIIT به عنوان یک روش غیر دارویی و موثر، می‌‌تواند مقدار سرمی آسپروسین و پروفایل لیپیدی را در زنان دارای اضافه وزن و چاق کاهش دهد و ترکیب بدنی آن ها را بهبود بخشد. 

کلیدواژه‌ها

عنوان مقاله [English]

The effect of high-intensity interval training on serum Asprosin and lipid profile of overweight and obese women

نویسندگان [English]

  • Parvane Dolataabadi 1
  • Ramin Amirsasan 2
  • Javad Vakili 3

1 PhD Student in Exercise Physiology, Faculty of Physical Education and Sports Sciences, University of Tabriz, Tabriz, Iran.

2 Professor in Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, University of Tabriz, Tabriz, Iran

3 Associate Professor in Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, University of Tabriz, Tabriz, Iran.

چکیده [English]

Background and Aim: Asprosin where secreted from adipose tissue plays a key role in regulating glucose metabolism and appetite, and could be a therapeutic target for the prevention of diseases such as obesity, type II diabetes, and insulin resistance. Therefore, the present study aimed to investigate the effect of high-intensity interval training (HIIT) on serum Asprosin and lipid profile in overweight and obese women. Materials and Methods: Thirty overweight and obese women (BMI≥28) with an age range of 30-45 years were purposefully selected in a quasi-experimental research with pre - test to post-test design. They randomly divided into two groups including 15 subjects in every HIIT and control group. The protocol was included preparation period for two weeks, eight weeks for the HIIT, and also they performed three sessions per week with 100% maximum reserve heart rate. Blood samples were taken before and 48 hours after the last training session (following 10 weeks of training). The amount of Asprosin and lipid profile were measured by ELISA and spectrophotometry methods respectively. Data were analyzed using Independent t-test and paired sample t-test at a significant level of p<0.05. Results: After 10 weeks of intervention, HIIT group showed a significant decrease in amount of Asprosin (p=0.02), triglyceride (p=0.01), total cholesterol (p=0.01), low density lipoprotein cholesterol (p=0.01), very low density lipoprotein cholesterol (p=0.01), weight (p=0.0001), fat percentage (p=0.0001) and BMI (p=0.0001), but a significant increase also observed in maximal oxygen consumption (p=0.0001). However, no significant increase in high density lipoprotein cholesterol (p>0.05) was observed. Conclusion: Probably HIIT as a non-pharmacological and effective method can reduce serum Asprosin and lipid profile in overweight and obese women and therefore improve their body composition.

کلیدواژه‌ها [English]

  • High Intensity Interval Training
  • Obese woman
  • Asprosin
  • Lipid profile
Adams, O.P. (2013). The impact of brief high-intensity exercise on blood glucose levels. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 6, 113-22. https://doi.org/10.2147/dmso.s29222.
Ahmadabadi, F., Nakhaei, H., Mogharnasi, M., & Huang, C.J. (2021). Aerobic interval training improves irisin and chemerin levels of both liver and visceral adipose tissues and circulating asprosin in rats with metabolic syndrome. Physiology International, 3(108), 383-397. https://doi.org/10.1556/2060.2021.00182.
Alan, M., Gurlek, B., Yilmaz, A., Aksit, M., Aslanipour, B., Gulhan, I., & Taner, C.E. (2019). Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecological Endocrinology, 35(3), 220-223. https://doi.org/10.1080/09513590.2018.1512967.
Beam, W.C., & Adams, G.M. (2011). Aerobic stepping. Exercise physiology laboratory manual. 6th ed. New York (NY): McGraw-Hill, 127-33. 
Bompa, T.O., & Buzzichelli, C. (2019). Periodization-: theory and methodology of training. Human kinetics. 5th edition. pp. 344-349. 
Ceylan, H. I., & Saygın, Ö. (2021). An investigation of the relationship between new fasting hormone asprosin, obesity and acute–chronic exercise: current systematic review. Archives of Physiology and Biochemistry, 127(4), 373-384. https://doi.org/10.1080/13813455.2020.1767652.
Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J.C., Romere, C., & Jain, M. (2017). Asprosin is a centrally acting orexigenic hormone. Nature Medicine, 23(12), 1444-1453. https://doi.org/10.1038/nm.4432.
Festiawan, R., Hoi, L. B., Siswantoyo, N., Kusuma, I. J., Heza, F. N., Wahono, B. S., ... & Sumartiningsih, S. (2021). high-intensity interval training, fartlek training & oregon circuit training: what are the best exercises to increase vo2 max. Annals of Tropical Medicine & Public Health, 24(03), 0-10. https://doi.org/10.36295/asro.2021.24363.
Gerosa-Neto, J., Antunes, B.M., Campos, E.Z., Rodrigues, J., Ferrari, G.D., Neto, J.C.R., & Bueno, C.R. (2016). Impact of long-term high-intensity interval and moderate-intensity continuous training on subclinical inflammation in overweight/obese adults. Journal of Exercise Rehabilitation, 12(6), 575. https://doi.org/10.12965/jer.1632770.385.
Gholaman, M., Gholami, M., Azarbayjani, M.A., & Abed Natanzi, H. (2021). The effect of high intensity interval training and moderate intensity continuous training on the levels of cardiotrophin-1and insulin resistance in women with type 2 diabetes. Journal of Basic Research in Medical Sciences, 8(1), 67-75. https://doi.org/10.20900/agmr20220007.
Gibala, M.J., Little, J.P., MacDonald, M.J., & Hawley, J.A. (2012). Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. The Journal of Physiology, 590(5), 1077-1084. https://doi.org/10.1113/jphysiol.2011.224725.
Guiraud, T., Labrunée, M., Pillard, F., Granger, R., Bousquet, M., Richard, L., ... & Gremeaux, V. (2014). Copyeditor: Patricia Llenado.  American Journal of Physical, 894(9115/14), 0000-0000. https://doi.org/10.1097/PHM.0000000000000181 
Ham, D., & Joung, H. (2020). Understanding the associations between dietary antioxidants and obesity. Journal of Obesity & Metabolic Syndrome, 29(3), 163. https://doi.org/10.7570/jomes20070.
Hatipoglu, H. (2020). Increased serum circulating asprosin levels in children with obesity. Pediatrics International: Official Journal of the Japan Pediatric Society, 62, 467–476. https://doi.org/10.1111/ped.14176.
Hong, T., Li, J. Y., Wang, Y. D., Qi, X. Y., Liao, Z. Z., Bhadel, P., ... & Xiao, X. H. (2021). High serum asprosin levels are associated with presence of metabolic syndrome. International Journal of Endocrinology, 2021, 1-7. https://doi.org/10.1155/2021/6622129.
Hunschede, S., Kubant, R., Akilen, R., Thomas, S., & Anderson, G.H. (2017). Decreased appetite after high-intensity exercise correlates with increased plasma interleukin-6 in normal-weight and overweight/obese boys. Current Developments in Nutrition, 1(3), e000398. https://doi.org/10.3945/cdn.116.000398.
Jahangiri, M., Shahrbanian, S., & Hackney, A.C. (2021). Changes in the level of Asprosin as a novel adipocytokine after different types of resistance training. Journal of Chemical Health Risks, 11(Spec Issue), 179-188. 
Johnson, R., McNutt, P., MacMahon, S., & Robson, R. (1997). Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clinical Chemistry, 43(11), 2183-2184. https://doi.org/10.1093/clinchem/43.11.2183.
Jung, T.W., Kim, H.C., Kim, H.U., Park, T., Park, J., Kim, U., & Jeong, J H. (2019). Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle. Journal of Cellular Physiology, 234(11), 20888-20899. https://doi.org/10.1002/jcp.28694.
Kantorowicz, M., Szymura, J., Szygula, Z., Kusmierczyk, J., Maciejczyk, M., & Wiecek, M. (2021). Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders. Frontiers in Physiology, 12, 726783. https://doi.org/10.3389/fphys.2021.726783.
Karstoft, K., Winding, K., Knudsen, S. H., Nielsen, J. S., Thomsen, C., Pedersen, B. K., & Solomon, T. P. (2013). The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care, 36(2), 228-236. https://doi.org/10.2337/dc12-0658.
Ko, J.R., Seo, D.Y., Kim, T.N., Park, S.H., Kwak, H.-B., Ko, K.S., . . . & Han, J. (2019). Aerobic exercise training decreases hepatic asprosin in diabetic rats. Journal of Clinical Medicine, 8(5), 666. https://doi.org/10.3390/jcm8050666.
Li, E., Shan, H., Chen, L., Long, A., Zhang, Y., Liu, Y., & Li, T. (2019). OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metabolism, 30(2), 319-328. e318. https://doi.org/10.1016/j.cmet.2019.05.022.
Li, X., Liao, M., Shen, R., Zhang, L., Hu, H., Wu, J., ... & Zheng, H. (2018). Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators of Inflammation, 2018, 1-12. https://doi.org/10.1155/2018/7375294.
Löllgen, H., Böckenhoff, A., & Knapp, G. (2009). Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. International Journal of Sports Medicine, 30(03), 213-224. https://doi.org/10.1055/s-0028-1128150.
Mabhout Moghadam, T., Mosaferi Ziaaldini, M., Fathei, M., & Attarzadeh Hoseini, S. R. (2020). Review the effect of high intensity interval training on obesity-related hormones. Researches in Sport Sciences and Medical Plants, 1(1), 1-18. [In Persian]. https://doi.org/10.34172/hmj.2021.26.
Ma, H., Zhang, G., Mou, C., Fu, X., & Chen, Y. (2018). Peripheral CB1 receptor neutral antagonist, AM6545, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate induced obese mice. Frontiers in Pharmacology, 9, 156. https://doi.org/10.3389/fphar.2018.00156.
Margiana, R., Jusuf, A.A., & Lestari, S.W. (2009). Immunohistochemistry detection method of rejection reaction of human umbilical cord derived mesenchymal stem cell on rat sciatic nerve tissue. Journal of Global Pharma Technology, 10(07), 330-342.
Martins, C., Morgan, L., & Truby, H. (2008). A review of the effects of exercise on appetite regulation: an obesity perspective. International Journal of Obesity, 32(9), 1337-1347. https://doi.org/10.1038/ijo.2008.98.
Mirzaei, M., & Nikahi, F. (2020). Investigating the relationship between physical activity and blood lipid profile in Yazd residents: Resultsof Yazd health study (Yas). Scientific Research Monthly of Yazd Shahid Sadoughi University of Medical Sciences, 28(7), 2819-2832. [In Persian]. https://doi.org/10.18502/ssu.v28i7.4266.
Nakhaei, H., Mogharnasi, M., & Fanaei, H. (2019). Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome. Obesity Medicine, 15(2019) 100111. https://doi.org/10.1016/j.obmed.2019.100111.
Pawitan, J.A., Leviana, M., Sukmawati, D., Liem, I.K., Margiana, R., & Tarcisia, T. (2017). Prospect of umbilical cord mesenchymal stem cell culture waste in regenerative medicine. Journal of Global Pharma Technology, 9(7), 1-5. http://152.118.76.18:8080/jspui/handle/123456789/7040.
Ramos, J.S., Dalleck, L.C., Tjonna, A.E., Beetham, K.S., & Coombes, J.S. (2015). The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Medicine, 45(5), 679-692. https://doi.org/10.1007/s40279-015-0321-z.
Rebello, C.J., Kirwan, J.P., & Greenway, F.L. (2020). Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? International Journal of Obesity, 44, 1810–1817. https://doi.org/10.1038/s41366-020-0640-5.
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., & York, B. (2016). Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165(3), 566-579. https://doi.org/10.1016/j.cell.2016.02.063.
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2016). Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Research Reviews, 28, 15-26. https://doi.org/10.1016/j.arr.2016.04.003.
Seo, D.Y., Ko, J.R., Bang, H.S., & Han, J. (2020). Exercise decreases hepatic asprosin in stz-induced diabetic rats. Metabolism-Clinical and Experimental, 104S(2020) 154076. https://doi.org/10.1016/j.metabol.2019.12.022.
Ugur, K., & Aydin, S. (2019). Saliva and blood asprosin hormone concentration associated with obesity. International Journal of Endocrinology. 2521096, 8. https://doi.org/10.1155/2019/2521096.
Wang, Y., Qu, H., Xiong, X., Qiu, Y., Liao, Y., Chen, Y., & Zheng, H. (2018). Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators of Inflammation. 9471583, 7. https://doi.org/10.1155/2018/9471583.
Weston, K.S., Wisløff, U., & Coombes, J.S. (2014). High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. British Journal of Sports Medicine, 48(16), 1227-1234 https://doi.org/10.1136/bjsports-2013-092576.
Wilson, L.F., Baade, P.D., Green, A.C., Jordan, S.J., Kendall, B.J., Neale, R.E., & Whiteman, D.C. (2019). The impact of changing the prevalence of overweight/obesity and physical inactivity in Australia: an estimate of the proportion of potentially avoidable cancers 2013–2037. International Journal of cancer, 144(9), 2088-2098. https://doi.org/10.1002/ijc.31943.
Yang, Z., Jiang, J., Huang, J., Zhao, Y., Luo, X., & Song, L. (2020). Effect of high-fat diet and exercise on asprosin and CTRP6 expression in subcutaneous and retroperitoneal adipose tissues in rats during mid-gestation. Journal of Southern Medical University, 40(10), 1406-1414. https://doi.org/10.12122/j.issn.1673-4254.2020.10.05.
Yuan, M., Li, W., Zhu, Y., Yu, B., & Wu, J. (2020). Asprosin: a novel player in metabolic diseases. Frontiers in Endocrinology, 11, 64 .  https://doi.org/10.3389/fendo.2020.00064.
Zarei, M., Khodakheyr, J. N., Rashidlamir, A., & Montazeri, A. (2021). The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes. Sport Sciences for Health,17, 863–871, 1-9. https://doi.org/10.1007/s11332-021-00738-7.
Zhang, L., Chen, C., Zhou, N., Fu, Y., & Cheng, X. (2019). Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clinica Chimica Acta, 489, 183-188. https://doi.org/10.1016/j.cca.2017.10.034.
Zhang, X., Jiang, H., Ma, X., & Wu, H. (2020). Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. Journal of Diabetes Investigation, 11(2), 349-355. https://doi.org/10.1111/jdi.13148.